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Edited by Jesus AvilaAbstract Botulinum neurotoxin A (BoNT A) is a substrate of
the Src family of tyrosine kinases. Here, we report that the
BoNT A light chain (LC) is phosphorylated in the tyrosine-71 lo-
cated at N-terminus. Covalent modiﬁcation of this residue nota-
bly increases the thermal stability of the endopeptidase activity,
without aﬀecting its catalytic eﬃcacy. Similarly, mutation of this
residue speciﬁcally aﬀected the protein stability but not its
endopeptidase function. Fusion of the Tat-translocating domain
to the N-terminus of the enzyme produced a cell permeable, func-
tional enzyme, as evidenced by immunocytochemistry and by the
cleavage of cytosolic SNAP25 in intact PC12 cells. Noteworthy,
truncation of cellular SNAP25 was reduced in cells when the Src
kinase activity was inhibited with a speciﬁc antagonist, implying
that tyrosine phosphorylation of BoNT A LC modulates the in
vivo proteolytic activity of the neurotoxin. Taken together, these
ﬁndings substantiate the tenet that tyrosine phosphorylation of
BoNT A LC could be an important modulatory strategy of the
neurotoxin stability and suggest that the phosphorylated neuro-
toxin may be a relevant molecule in vivo.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Botulinum neurotoxins (BoNTs) are a family of substrate-
speciﬁc, Zn2+-dependent endopeptidases that abrogate regu-
lated exocytosis [1]. These potent neurotoxins target the key
molecular components of the SNARE complex, thus impeding
the fusion of neurotransmitter-loaded vesicles with the presy-
naptic membrane. For instance, BoNT A, C and E truncate
SNAP25, while BoNT B, D, F and G cleave VAMP2, and
BoNT C also proteolyzes syntaxin [1,2]. Biochemically, BoNTs
are proteins composed of a heavy chain (HC) of 100 kDa, and
a light chain (LC) of 50 kDa that contains the catalytic domain
that truncates the SNARE proteins [1,2].
We previously demonstrated that both the HC and the LC
of native BoNTs are substrates of the Src tyrosine-speciﬁc pro-
tein kinase [3]. Tyrosine phosphorylation of the BoNT A LC
occurred in vitro as well as in vivo. Covalent modiﬁcation of
native BoNT A LC gave rise to prominent augmentation of*Corresponding author. Fax: +34 966658758.
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with a disorder-to-order transition promoted by phosphoryla-
tion [3,4]. Similar results were obtained for native BoNT E
[3,4]. Surprisingly, however, covalent modiﬁcation of the rec-
ombinant BoNT E LC resulted in a modest increase in the pro-
tein thermal stability without altering its catalytic eﬃcacy [5],
implying diﬀerences between the native and recombinant pro-
teins. This apparent discrepancy led to the notion that stimu-
lation of the protease function may be due, at least partly, to
enhancement of LC dissociation from the holotoxin, rather
than direct modulation of the catalytic activity [5]. Nonethe-
less, additional studies are necessary to understand these as-
pects of BoNTs modulation by tyrosine phosphorylation.
Here, we have used recombinant, puriﬁed His-BoNT A LC
to further understand the role of tyrosine phosphorylation
modulating the protein structure–function relationships. We
report that His-BoNT A LC is phosphorylated by the Src
quinase at Y71, a tyrosine residue located at the N-terminus
of the neurotoxin. Tyrosine phosphorylation of His-BoNT A
LC enhanced its thermal stability without altering its catalytic
eﬃcacy, akin to the modulation exerted in the recombinant
catalytic domain of BoNT E [5]. Mutation of Y71 to phenyla-
lanine produced a mutant protein that was stable and virtually
identical to the non-phosphorylated form of the neurotoxin.
Replacement of Y71 by tryptophan, however, decreased the
thermal stability of the protein without aﬀecting its endopept-
idase activity. We also report that inhibition of Src activity in
PC12 cells notably reduced His-BoNT A LC-mediated trunca-
tion of SNAP25. Therefore, these results imply that tyrosine
phosphorylation of the neurotoxin by Src plays a role in mod-
ulating the stability of the protein in vitro and in vivo.2. Materials and methods
2.1. Cloning, mutagenesis, expression and puriﬁcation of recombinant
His-BoNT A LC species and SNAP25
The full-length of His-BoNT A LC (strain 62A) cloned into the
pQE3 vector was kindly provided by Dr. Blasi [6,7]. This cDNA was
inserted into the pTat-HA plasmid (kindly provided by Dr. Dowdy)
to obtain the Tat-His-BoNT A LC. Site-speciﬁc mutagenesis was car-
ried out by PCR ampliﬁcation as described [5]. Mutants were con-
ﬁrmed by DNA sequencing.
His-BoNT A LC species were aﬃnity-puriﬁed on Ni–NTA columns
(Qiagen) as described [5]. Brieﬂy, His-BoNT A LC was expressed in the
Escherichia coli strain M15pREP4 and protein expression was induced
with 1 mM Isopropyl-b-thiogalactoside (IPTG) at 30 C for 5 h. Bac-
teria were collected by centrifugation, resuspended in 10 mM phos-
phate, pH 7.4, 140 mM NaCl, and 3 mM KCl (PBS), digested withation of European Biochemical Societies.
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dazole, and 2 mM phenylmethylsulfonylﬂuoride, 5 mM iodoaceta-
mide, 2 mM EDTA, and sonicated in a Branson Soniﬁer Cell
Disruptor 250 at 4 C. Bacterial extracts were clariﬁed by centrifuga-
tion and incubated with Ni–NTA resin (1 ml/1 L culture) overnight
at 4 C. His-tagged BoNT A LC was extensively washed with PBS/imi-
dazole (20 mM) and eluted from the column with PBS, pH 7.0, supple-
mented with 100 mM imidazol. Tat-His-BoNT A LC was eluted with
500 mM imidazole. Protein eluates were dialyzed against 20 mM Tris,
pH 7.0, and 100 mM NaCl for 24 h at 4 C. Purity of the protein was
evaluated by SDS–PAGE and protein concentration was determined
with the BCA kit (Pierce).
2.2. Expression and puriﬁcation of SNAP25
Recombinant GST-SNAP25 was expressed in E. coli strain
BL21(DE3) and aﬃnity-puriﬁed on glutathione–agarose columns as
described in detail elsewhere [5,8]. Resin-bound GST-SNAP25 was re-
leased by digestion with thrombin protease for 5 h at 23 C. SNAP25
was dialyzed into 20 mMHEPES, pH 7.4, 80 mMKCl for 24 h at 4 C.
Protein concentration was assayed with the BCA kit (Pierce) and pur-
ity by SDS–PAGE analysis.2.3. Phosphorylation of His-BoNT A LC
Src-mediated phosphorylation of His-BoNT A LC species was per-
formed with recombinant Src kinase (Upstate Biotech. Inc.) as previ-
ously described [3–5]. Brieﬂy, 0.5 lM His-BoNT A LC was
incubated with 3 U of Src in 20 mM HEPES, pH 7.4, 20 mM MgCl2,
1 mM EGTA, 2 mM EDTA and 0.5 mM ATP at 30 C for the indi-
cated times. Tyrosine phosphorylation was evaluated by Western
immunoblot with an anti-phosphotyrosine monoclonal antibody (Sig-
ma) [3,5].2.4. Endopeptidase activity of His-BoNT A LC
The proteolytic activity was assayed in vitro using 6 lM SNAP25 as
described [3,5]. Brieﬂy, cleavage assays (20 ll) were performed in 20
mM HEPES, pH 7.4, 2 mM DTT, 10 lM Zn(CH3COO)2 at 30 C
for the indicated times. The extent of SNAP25 cleavage was evaluated
by native PAGE. Gels were digitized and quantiﬁed as reported [3,5].
2.5. Circular dichroism spectroscopy
Circular dichroism (CD) was carried out in a JASCO J-810 Spectro-
polarimeter equipped with a computer-controlled temperature cuvette
holder. CD data for the Far-UV CD spectra (region 195–260 nm) were
recorded with a 1 mm path length cell containing 4 lM protein in 20
mM Tris–HCl, pH 7.0. All spectra were recorded at 25 C and at 50
nm/min (response time of 1 s), averaged (5 scans), and corrected for
the buﬀer contribution. CD signals (in mdegrees) were converted to
mean ellipticity (h, mdegrees cm2 dmol1) [5]. Secondary structure ele-
ments were inferred by ﬁtting the CD spectra as described [5,8,9]. Ther-
mal denaturation was accomplished by recording the CD spectra at
increasing temperatures of 20–80 C.2.6. Cell culture and immunocytochemistry
PC12 cells were cultured in DMEM plus 10% horse serum and 5%
bovine serum as described [3]. Cell cultures were incubated with 300
nM Tat-His-BoNT A LC or His-BoNT A LC for 3 h at 37 C. For
immunocytochemistry, PC12 were extensively washed with cold PBS,
ﬁxed, blocked, permeabilized and, subsequently, incubated with anti-
His monoclonal antibody (mAb) (1:2000) (Sigma) [9,10]. After wash-
ing, they were incubated with Alexa 488-coupled secondary antibody
and propidium iodide, washed, embedded and analyzed by confocal
microscopy (Leica TCS) [10].
The extent of cellular SNAP25 cleavage was determined in whole cell
extracts of control and neurotoxin-intoxicated PC12 cells by Western
immunoblots using an anti-SNAP25 antibody (Alomone Lab) [3].3. Results
To study the functional and structural role of tyrosine phos-
phorylation of the BoNT A catalytic domain, we expressedand puriﬁed His-tagged BoNT A LC. IPTG induced the syn-
thesis of a soluble protein with an apparent mobility of 58
kDa that was speciﬁcally retained on a Ni–NTA aﬃnity chro-
matography column (Fig. 1A). The His-BoNT A LC was
eluted with 100 mM imidazole (Fig. 1A, lane 5) and conﬁrmed
by Western immunoblotting using an anti-His mAb (data not
shown). This experimental paradigm produced 7 mg protein/L
of bacterial cultures of a fairly homogeneous (P 90%) His-
BoNT A LC fusion protein.
We next determined if the puriﬁed His-BoNT A LC exhib-
ited proteolytic activity. For this task, we used recombinantly
produced SNAP25 as a substrate [8]. Incubation of the sub-
strate with increasing concentrations of the His-BoNT A LC
at 30 C for 60 min resulted in complete cleavage of SNAP25
at [His-BoNT A LC] P 5 nM (Fig. 1B, top). The estimated
concentration of recombinant neurotoxin needed to cleave half
of the maximal substrate concentration (EC50) was 1.8 ± 0.3
nM (Fig. 1C), which is signiﬁcantly higher than that reported
for recombinant BoNT E LC [5]. Most surprisingly, analysis of
the thermal stability of the enzymatic activity revealed that
pre-incubation of 20 nM His-BoNT A LC at 30 C for 60
min, before adding SNAP25, caused complete inactivation
(Fig. 1B, bottom). This result is consistent with the previously
reported thermosensitivity of the catalytic activity of the native
neurotoxin that was abrogated by pre-incubation at 37 C [3].
Taken together, these observations suggest that the enzymatic
activity of the BoNT A LC is thermally sensitive.
To investigate whether the thermal instability is due to the
presence of unfolded protein, the structural characteristics of
the His-BoNT A LC were studied by CD in the far-UV (Fig.
1D). The shape of the CD spectrum exhibits a double nega-
tive maxima at 207 and 222 nm, and a positive maximum
around 190 nm, consistent with the presence of an a-helical
secondary structure. Indeed, the apparent secondary struc-
tures inferred from the curve-ﬁtting of the CD spectra were
15% a-helix and 25% b-pleated sheets. CD spectra are quite
sensitive to structural changes caused by denaturating heat,
thus providing an operational assay to study the protein ther-
mostability. Speciﬁcally, we studied the variation of the h222
as a function of the temperature (Fig. 1D, inset). The exper-
imental data can be readily described by a sigmoidal curve
whose inﬂexion point corresponds to the denaturating tem-
perature, i.e., 47.3 ± 0.7 C. This value is remarkably higher
than that obtained for the catalytic activity (Fig. 1C), sug-
gesting that the temperature-induced loss of function is not
related to profound structural changes in the recombinant
protein, but rather may be due to subtle conformational
changes in the enzyme active site.
Tyrosine phosphorylation of clostridial BoNT A modulates
its catalytic activity and thermal stability [3,4]. Thus, we eval-
uated whether the recombinant His-BoNT A LC is a substrate
of the tyrosine kinase Src. As illustrated in Fig. 2A, incubation
of His-BoNT A LC with recombinant Src at 30 C resulted in a
time-dependent phosphorylation with t1/210 min and satura-
tion at 60 min. No phosphorylation of His-BoNT A LC was
observed when the ATP was omitted from the reaction (data
not shown). To investigate the eﬀect of the phosphorylation
on the catalytic eﬃcacy, the recombinant neurotoxin was phos-
phorylated with Src at 30 C for 60 min, and thereafter the
enzymatic eﬃcacy of the phosphorylated and unphosphoryl-
ated proteins was assessed in vitro using recombinant
SNAP25. Unphosphorylated samples refer to His-BoNT A
Fig. 1. (A) Puriﬁcation of BoNT A LC on a Ni2+–NTA aﬃnity chromatography. Protein fractions were separated on 10% Tris–glycine SDS–PAGE
gels and stained with Coomassie blue. Lane 1. Molecular weight markers; Lane 2. Induced bacterial culture; Lane 3. Soluble fraction; Lane 4, Flow
through Ni–NTA resin; Lane 5, 100 mM imidazole eluted protein. (B) (Top) His-BoNT A LC is an active endoprotease that cleaves SNAP25.
(Bottom) Pre-incubation of His-BoNT A LC at 30 C for 60 min abolishes endopeptidase activity. ct, denotes 5 nM His-BoNT A LC; u and c
correspond to uncleaved and cleaved SNAP-25, respectively. (C) Quantiﬁcation of the percentage of SNAP25 cleavage as a function of the His-BoNT
A LC. Native PAGE gels were air-dried, digitalized and band quantiﬁed as described [5]. Solid lines depict the best ﬁt to a Michaelis–Menten binding
isotherm. The estimated EC50 was 1.8 ± 0.3 nM. Enzymatic reactions were performed with 6 lM SNAP25 at 30 C for 1 h. (D) CD spectrum of 4 lM
His-BoNT A LC at 16 C (inset). Thermal denaturation of His-BoNT A LC, as determined from analysis of the CD spectra at increasing
temperatures [5]. Solid line depicts the best ﬁt to a sigmoidal curve. Denaturating temperature was 47.3 ± 0.7 C.
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absence of ATP. As expected, unphosphorylated enzyme was
not active even at 20 nM, due to thermal inactivation of the
catalytic activity after 60 min incubation at 30 C (Fig. 2B,
inset). In marked contrast, phosphorylated His-BoNT A LC
virtually cleaved all SNAP25 at concentrations P 2 nM. A
dose–response relationship provided an EC50 of 1.3 ± 0.3 nM
for the phosphorylated enzyme. Therefore, these data suggest
that tyrosine phosphorylation of the recombinant catalytic do-
main prevents or delays thermal enzymatic inactivation, but it
does not aﬀect the catalytic eﬃcacy of the enzyme. Next, we
attempted to study the phosphorylation-induced structural
changes in the BoNT A LC by CD. However, the phosphoryl-
ated neurotoxin aggregated and precipitated out at concentra-
tions P 1 lM, thus precluding the conformational analysis.
Tyrosine phosphorylation appears conserved among all clo-
stridial neurotoxins, suggesting the presence of a conserved
phosphoacceptor site [3,5]. In the BoNT E LC, the phosphory-
lation site was mapped at Y67 [5], which corresponds to Y71 in
BoNT A LC. Indeed, mutation of Y71 to F (Y71F) fully abol-
ished Src-mediated tyrosine phosphorylation of the His-BoNT
A LC (Fig. 2C, inset), thus demonstrating that Y71 is the only
phosphate acceptor site. The Y71F mutant was stable and
exhibited functional and structural properties that were virtu-
ally identical to those characteristic of the wild type protein,
namely an EC50 of 1.8 nM for cleaving SNAP25, a 15% con-
tent in a-helical elements and a denaturating temperature of
48 ± 0.2 C (Fig. 2D and E). Replacement of Y71 by W(Y71W) yielded a protein that showed unaltered catalytic
activity (EC50 = 1.6 nM) (Fig. 2C) and denaturated at lower
temperature (42 ± 0.5 C) (Fig. 2D and E). Incorporation of
a negatively charged amino acid at position Y71 (Y71E) re-
sulted in an unstable protein that aggregated and accumulated
in bacterial inclusion bodies, preventing their functional puri-
ﬁcation and characterization. Taken together, these results im-
ply that the Y71 site is an important determinant of the
protease stability, but plays a marginal role in the protein cat-
alytic activity.
We have previously shown that BoNT A LC is tyrosine-
phosphorylated in PC12 cells [3]. Thus, we hypothesized that
cellular tyrosine kinase activity may modulate the function of
recombinant BoNT A LC. To address this issue, we used the
fusion Tat-His-BoNT A LC protein that incorporated the
Tat translocation sequence at the N-end of the neurotoxin
catalytic domain [11]. Tat-His-BoNT A LC was expressed
in bacteria and puriﬁed by aﬃnity chromatography with
Ni–NTA (Fig. 3A). Fusion of the Tat domain did not aﬀect
the in vitro enzymatic activity of the protein, as evidenced by
the virtually identical eﬃcacy cleaving SNAP25 of Tat-His-
BoNT A LC as that exhibited by the His-BoNT A LC
(Fig. 3B). Next, we investigated whether the Tat-His-BoNT
A LC translocated through plasma membrane of PC12 cells.
For this task, cell cultures were incubated with 300 nM of the
protein at 37 C for 3h. The intracellular localization of the
protein was evaluated by immunocytochemistry using an
anti-His mAb. As shown in Fig. 3C, PC12 cells incubated
Fig. 2. (A) Src kinases phosphorylate His-BoNT A LC. Tyrosine phosphorylation reaction was carried out using 3 U of Src kinase and 10 nM of
BoNTA-LC at 30 C, and determined by Western inmunoblotting using an anti-phosphotyrosine antibody. Protein bands were visualized with the
ECL. Protein immunoblots were digitized and band quantiﬁed as described [5,10]. (B) Endopeptidase activity as a function of the concentration of
unphosphorylated (U) and tyrosine phosphorylated (P) His-BoNT A LC. The neurotoxin was phosphorylated for 60 min at 30 C. The catalytic
activity was assayed on 6 lM SNAP25 at 30 C for 60 min, at the indicated enzyme concentrations. The extent of SNAP25 cleavage was analyzed
native PAGE electrophoresis as described in the legend of Fig. 1. u and c correspond to uncleaved and cleaved SNAP-25, respectively. Solid lines
depict the best ﬁt to a Michaelis–Menten binding isotherm. The estimated EC50 for the phosphorylated His-BoNT A LC was 1.3 ± 0.3 nM. (C)
Mutation of Y71 to F abolishes tyrosine phosphorylation of His-BoNT A LC (inset). Catalytic activity of Y71F and Y71W mutants of His-BoNT A
LC. The calculated EC50 were 1.6 ± 0.5 nM and 1.8 ± 0.4 nM for Y71F and Y71W, respectively. (D) CD spectra of Y71F and Y71F mutant proteins.
(E) Thermal denaturation of Y71F and Y71F mutant enzymes determined from analysis of the CD spectra at increasing temperatures. Solid lines
depict the best ﬁt to a sigmoidal curve. Denaturating temperatures were 480.2 C for Y71F and 42 ± 0.5 C for Y71W. Protein concentration was 4
lM.
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intracellular immunostaining, indicating the presence of the
protein (Fig. 3C, top, left). Note that, as expected, the Tat-
tagged protein accumulated primarily in the nucleus of the
cells (Fig. 3C, top, right). In contrast, cells exposed to 300
nM His-BoNT A LC did not show an immunocytochemical
labeling (Fig. 3C, Bottom). To further demonstrate the trans-
location of the Tat-His-BoNT A LC into intact PC12 cells,
we evaluated the integrity of cellular SNAP25 by Western
immunoblotting using an anti-SNAP25 antibody. Fig. 3D
shows that the SNAP25 of PC12 cells exposed to Tat-His-
BoNT A LC was P 50% cleaved, while that of cultures incu-
bated with His-BoNT A LC remained intact. Note that
SNAP25 cleavage exerted by Tat-His-BoNT A LC in intact
cells was comparable to that elicited by the native neurotoxin
[3]. Collectively, these results indicate that the Tat-His-BoNT
A LC is a functional enzyme that translocates through the
plasma membrane of PC12 cells.
To evaluate the role of tyrosine kinase in the in vivo activity
of BoNT A LC, we studied the cleavage activity of the Tat-
His-BoNT A LC in cells exposed to PP2 (4-amino-5-[4-chloro-
phenyl]-7-[t-butyl]pyrazolo[3]pyrimidine), a speciﬁc inhibitor
of the Src family of tyrosine kinases [12]. Incubation of
PC12 cells with 10 nM PP2 notably aﬀected the level of tyro-sine phosphorylated proteins, as revealed by Western immuno-
blot of PC12 whole extracts probed with an anti-
phosphotyrosine mAb (data not shown). Noteworthy, the
presence of the Src inhibitor reduced the extent of BoNT A-
mediated, SNAP25 cleavage by P 50% (Fig. 3E and F).
Therefore, this ﬁnding is consistent with the tenet that tyro-
sine phosphorylation of BoNT A LC modulates its in vivo
functionality.4. Discussion
The salient contribution of this study is that phosphoryla-
tion of BoNT A LC notably enhances its thermal stability,
akin to the observations reported for the recombinant BoNT
E LC [5]. In addition, they corroborate that tyrosine phos-
phorylation does not modulate the catalytic activity of the rec-
ombinant protein. Thus, the proposed enhancement of
catalytic eﬃcacy exerted by tyrosine phosphorylation on the
native neurotoxin may rather arise from a facilitation of the
dissociation of the BoNT A LC form holotoxin and/or stabili-
zation of the separated catalytic domain [3]. As for the holo-
toxin and the recombinant BoNT E LC, the higher
thermostability of the BoNT A LC activity may be due to a
Fig. 3. (A) Tat-His-BoNTA LC was puriﬁed by aﬃnity chromatography. Lane 1: soluble fraction; lane 2: ﬂow through Ni–NTA resin; lane 3:
protein eluted with 500 mM imidazole; lane 4: molecular weight markers. (B) Tat-His-BoNT A LC is an active endoprotease that cleaves SNAP25 in
vitro. Enzymatic reactions were carried out with 6 lM SNAP 25 and 50 nM of endopeptidases at 30 C for 1 h as described. u and c correspond to
uncleaved and cleaved SNAP-25, respectively. (C) Intracellular localization of Tat-His-BoNT A LC in PC12 cells. Neurotoxin-exposed cell cultures,
ﬁxed, detergent-permeabilized and probed with anti-His mAb. Immunocomplexes were visualized with Alexa 488-coupled anti-mouse as secondary
antibody (left panels). The cell nucleus was stained with propidium iodide and images overlapped with those of anti-His (right panels). (D) Cleavage
of cellular SNAP25 with Tat-His-BoNT A LC in intact PC12 cells. Control, denotes the protease activity of 100 nM Tat-His-BoNT A LC in whole
cell extracts. SNAP-25 cleavage was determined by immunoblotting using an anti-SNAP25 antibody. (E) Inhibition of Src kinase reduces SNAP 25
cleavage by Tat-His-BoNT A LC. PC-12 cells were exposed to Tat-His-BoNT A LC in the absence or presence of 10 nM PP2. Cell cultures were
washed and detergent-permeabilized to determine the extent of SNAP25 cleavage. (F) Quantiﬁcation of PP2 inhibitory eﬀect of SNAP25 truncation
by Tat-His-BoNT A LC. Cell cultures were incubated with 300 nM of Tat-His-BoNTA LC or His-BoNT A LC at 37 C for 3 h, washed with PBS,
before detergent permeabilization.
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However, the remarkable tendency of the phosphorylated pro-
tein to aggregate at P 1 lM prevented the structural analysis.
Our results substantiate that a single, evolutionary con-
served tyrosine residue (Y71 in BoNT A LC) at the N-terminus
of BoNTs is the phosphate acceptor site [5,13]. The three
dimensional structure of the native and recombinant BoNT
A LCs, as well as that of BoNT B LC, shows that the spatial
location of this residue is compatible with the impact of its
covalent modiﬁcation on the enzyme properties [14–17]. As de-
picted in Fig. 4A, the aromatic ring of residue Y71 is located in
a small hydrophobic pocket, while its hydroxyl group is sol-
vent-exposed and accessible to the Src kinase. Replacement
of Y71 by its phosphorylated counterpart in the BoNT A
LC structure shows the occurrence of a strong hydrogen bond
interaction of the phosphotyrosine with R374 and with the car-
bonyl group of L415 at the C-end (Fig. 4B). As a result, the
compactness of the proteins appears to increase, a notion con-
sistent with the higher thermostability of the phosphorylated
protein [4,5]. Notice that a W at Y71 does not ﬁt into the small
cavity that accommodates the residue (Fig. 4C) and that muta-
tion Y71E incorporates a charged residue into this hydropho-
bic pocket (Fig. 4D). These unfavorable conditions explain the
destabilizing eﬀects of these two mutations. Indeed, the esti-mated variations of free energy of the folded state with respect
to wild type endopeptidase (DDG) are 2.2 kcal/mol and 3.1
kcal/mol for Y71W and Y71E mutants (calculated with
Fold-X). Although these interpretations appear reasonable,
the precise structural modulation exerted by phosphorylation
will have to be addressed by determining the structure of the
phosphorylated enzyme.
We previously demonstrated that BoNT A LC is tyrosine
phosphorylated in PC12 cells, implying that this convalent
modiﬁcation may play a role in the biological function of the
protein [3]. Here, we have shown that incubation of Tat-BoNT
A LC intoxicated cells with a speciﬁc, cell-permeable inhibitor
of the Src kinase signiﬁcantly decreased the extent of SNAP25
cleavage, thus suggesting that the phosphorylated enzyme con-
tributes to the in vivo cleavage of SNAP25. Since the BoNT A
LC translocates unfolded through the HC [18], it is tempting to
hypothesize that phosphorylation-induced conformational
changes may contribute to stabilization of the re-folded pro-
tein. Collectively, all our ﬁndings lend further support to the
tenet that phosphorylation may contribute to the in vivo bio-
logical behavior of BoNT A. Furthermore, they suggest that
acute inhibition of the Src family of tyrosine kinases may be
a therapeutic strategy for treating botulinum poisoning. Addi-
tional studies are needed to precisely unveil the physiological
Fig. 4. (A) Residue Y71 is located in a small hydrophobic cavity, but it has its hydroxyl group exposed and accessible to the Src kinase. (B)
Phosphorylation of Y71 strengthens the interaction with R474 and L415, inducing a conformation change that increases the compactness of the
protein. (C) A tryptophan does not ﬁt into the cavity, thus distorting the structure. (D) A glutamic acid would lie into a hydrophobic pocket, thus
destabilizing the folded protein. The structure of the BoNT A LC as used as a scaﬀold (PDB 1E1H) [14]. The free energy of the folded state of wild
type and mutants was calculated with Fold-X (http://fold-x.embl.de). Oxygens are showed in red, nitrogens in blue, and phosphate in yellow.
126 C. Iban˜ez et al. / FEBS Letters 578 (2004) 121–127role of the in vivo phosphorylation of BoNT A LC. It did not
escape from our attention that the Tat-BoNT A LC fusion
protein or more stable species could be enzymes with improved
clinical utility. Indeed, at variance with the high molecular
complexity of the current clinical preparations [19], the rec-
ombinant catalytic domain might provide a rather homogene-
ous therapeutic formulation.
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